Our group developed small-sized human serum albumin (HSA)–ICG–iRGD nanoprobes to serve as theranostic agents for NIR-II fluorescence imaging and phototherapy of glioma (Fig. 9A to C) [125]. The gene discussed is ALB; the disease is central nervous system cancer.